Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

RomaniaBack to Romania

Clinical trials in Bistrița

2 clinical trials in Bistrița, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Bistrița at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Bistrița

Open in trial search

Hereditary haemochromatosis

Recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:VAMIFEPORT TRIHYDROCHLORIDE
  • Sponsor:CSL Behring LLC

Breast cancer+1

Recruiting
Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Bistrița

What the registry says about research in the country

01 Bistrița
Neoplasms
Researchers in Bistrița are conducting a trial that examines a novel antibody‑drug conjugate for patients with triple-negative breast cancer and other HER2‑negative tumors, aiming to identify the optimal dose and compare its effectiveness against standard chemotherapy options. Evaluation of a novel antibody‑drug conjugate Comparison with standard chemotherapy regimens Focus on patients with inoperable or metastatic disease Assessment of safety and efficacy The study is actively recruiting, offering participants access to cutting‑edge treatment while contributing to improved therapeutic strategies for aggressive breast cancer subtypes.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
An ongoing investigation in Bistrița focuses on adults with hereditary hemochromatosis caused by HFE gene mutations, testing the iron‑chelator vamifeport and measuring its impact on MRI‑based liver iron concentration. Evaluation of iron reduction therapy Use of MRI to monitor liver iron levels Inclusion of adult participants with HFE‑related disease Safety profile assessment Recruitment is open, and the trial seeks to improve disease management by providing a targeted approach to reduce hepatic iron overload.
Back to RomaniaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.